ZA200804266B - Therapeutic uses of steroidal compounds - Google Patents
Therapeutic uses of steroidal compoundsInfo
- Publication number
- ZA200804266B ZA200804266B ZA200804266A ZA200804266A ZA200804266B ZA 200804266 B ZA200804266 B ZA 200804266B ZA 200804266 A ZA200804266 A ZA 200804266A ZA 200804266 A ZA200804266 A ZA 200804266A ZA 200804266 B ZA200804266 B ZA 200804266B
- Authority
- ZA
- South Africa
- Prior art keywords
- therapeutic uses
- steroidal compounds
- steroidal
- compounds
- therapeutic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000003637 steroidlike Effects 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0523550.2A GB0523550D0 (en) | 2005-11-18 | 2005-11-18 | Therapeutic uses of steroidal compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200804266B true ZA200804266B (en) | 2009-01-28 |
Family
ID=35580318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200804266A ZA200804266B (en) | 2005-11-18 | 2008-05-16 | Therapeutic uses of steroidal compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8846652B2 (https=) |
| EP (1) | EP1948192A2 (https=) |
| JP (1) | JP5395437B2 (https=) |
| KR (1) | KR101314694B1 (https=) |
| CN (1) | CN101346144B (https=) |
| AU (1) | AU2006314226B2 (https=) |
| CA (1) | CA2630441C (https=) |
| GB (1) | GB0523550D0 (https=) |
| IL (1) | IL191457A (https=) |
| MX (1) | MX2008006440A (https=) |
| NO (1) | NO20082741L (https=) |
| NZ (1) | NZ568560A (https=) |
| RU (1) | RU2427375C2 (https=) |
| TW (1) | TWI386211B (https=) |
| WO (1) | WO2007057691A2 (https=) |
| ZA (1) | ZA200804266B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU20110244A7 (es) | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
| CN108434090A (zh) * | 2017-02-14 | 2018-08-24 | 高药品股份有限公司 | 以生理脂肪为基剂的类固醇药膏 |
| RU2745868C9 (ru) * | 2020-05-28 | 2021-04-08 | Федеральное государственное бюджетное образовательное учреждение высшего образования «Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва» | Способ ускорения регенерационных процессов в поврежденных периферических нервах |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012997A1 (en) | 1991-01-16 | 1992-08-06 | The General Hospital Corporation | Human galanin |
| WO1992015015A1 (en) | 1991-02-25 | 1992-09-03 | Zymogenetic, Inc. | Methods for detecting galanin antagonists |
| DE69225706T2 (de) | 1991-03-06 | 1998-11-26 | Garvan Institute Of Medical Research, Darlinghurst, Neu Sued Wales/New South Wales | Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen |
| SE9101472D0 (sv) | 1991-05-15 | 1991-05-15 | Trion Forskning & Utveckling | Galanin antagonist |
| JPH06172387A (ja) | 1992-12-11 | 1994-06-21 | Aibaitsu Kk | 合成ペプチド誘導体 |
| EP0698612B1 (en) * | 1993-05-18 | 2001-07-25 | Ltt Institute Co., Ltd. | Osteogenesis promoter and osteoporosis remedy |
| JPH09151197A (ja) * | 1995-11-29 | 1997-06-10 | L T T Kenkyusho:Kk | 自己免疫疾患治療薬 |
| DE69739760D1 (de) | 1996-07-24 | 2010-03-25 | Neurotargets Ltd | Verwendung eines Galanin-agonisten in der Herstellung eines Medikaments zur Verbesserung des Gedächtnisses und anderer cognitiver Funktionen |
| JP2000169374A (ja) * | 1998-12-03 | 2000-06-20 | Ltt Kenkyusho:Kk | Ｉｇｆ増強剤 |
| TR200200406T2 (tr) * | 1999-06-11 | 2002-06-21 | Watson Pharmaceuticals, Inc. | Kadınlara oral olmayan yollarla androjenik steroidlerin uygulanması |
| DE10054294A1 (de) * | 2000-11-02 | 2002-05-16 | Heinrich Wieland | Topische Behandlung bei der Mastalgie |
| GB0105772D0 (en) * | 2001-03-08 | 2001-04-25 | Sterix Ltd | Use |
| DE60120104T2 (de) | 2001-03-20 | 2006-09-21 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz |
| WO2002096934A1 (en) | 2001-05-25 | 2002-12-05 | Kemia, Inc. | Non-natural galanin receptor ligands |
| DK1406606T3 (da) | 2001-07-16 | 2007-03-05 | Ortho Mcneil Pharm Inc | Carbamatforbindelser til forebyggelse eller behandling af neuropatisk smerte og smerte forbundet med klynge- og migrænehovedpine |
| JP2004538305A (ja) | 2001-07-31 | 2004-12-24 | ファルマシア・アンド・アップジョン・カンパニー | ３−ヘテロシクリル−及び３−シクロアルキル−３−アリールオキシプロパンアミンによる慢性疼痛の治療 |
| WO2003011272A1 (en) | 2001-07-31 | 2003-02-13 | Pharmacia & Upjohn Company | Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| ATE332688T1 (de) | 2001-10-16 | 2006-08-15 | Endo Pharmaceuticals Inc | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung |
| GB0403509D0 (en) | 2004-02-17 | 2004-03-24 | Neuro Targets Ltd | Galanin receptors and brain injury |
| US20070231373A1 (en) * | 2004-04-28 | 2007-10-04 | Hunter-Fleming Limited | Transdermal Steriod for Formulation |
| JP5449775B2 (ja) * | 2005-10-19 | 2014-03-19 | チャバフ ピーティーワイ エルティーディー | 乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減 |
| WO2008065408A2 (en) | 2006-11-30 | 2008-06-05 | Hunter-Fleming Limited | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
-
2005
- 2005-11-18 GB GBGB0523550.2A patent/GB0523550D0/en not_active Ceased
-
2006
- 2006-11-17 KR KR1020087014690A patent/KR101314694B1/ko not_active Expired - Fee Related
- 2006-11-17 WO PCT/GB2006/004305 patent/WO2007057691A2/en not_active Ceased
- 2006-11-17 NZ NZ568560A patent/NZ568560A/en not_active IP Right Cessation
- 2006-11-17 RU RU2008124834/15A patent/RU2427375C2/ru not_active IP Right Cessation
- 2006-11-17 JP JP2008540695A patent/JP5395437B2/ja not_active Expired - Fee Related
- 2006-11-17 US US12/094,079 patent/US8846652B2/en not_active Expired - Fee Related
- 2006-11-17 AU AU2006314226A patent/AU2006314226B2/en not_active Ceased
- 2006-11-17 EP EP06808592A patent/EP1948192A2/en not_active Withdrawn
- 2006-11-17 MX MX2008006440A patent/MX2008006440A/es active IP Right Grant
- 2006-11-17 CN CN2006800486827A patent/CN101346144B/zh not_active Expired - Fee Related
- 2006-11-17 CA CA2630441A patent/CA2630441C/en not_active Expired - Fee Related
- 2006-11-20 TW TW095142777A patent/TWI386211B/zh not_active IP Right Cessation
-
2008
- 2008-05-15 IL IL191457A patent/IL191457A/en not_active IP Right Cessation
- 2008-05-16 ZA ZA200804266A patent/ZA200804266B/xx unknown
- 2008-06-17 NO NO20082741A patent/NO20082741L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US8846652B2 (en) | 2014-09-30 |
| MX2008006440A (es) | 2008-12-01 |
| RU2008124834A (ru) | 2009-12-27 |
| JP5395437B2 (ja) | 2014-01-22 |
| WO2007057691A2 (en) | 2007-05-24 |
| TW200730180A (en) | 2007-08-16 |
| NZ568560A (en) | 2010-11-26 |
| CN101346144A (zh) | 2009-01-14 |
| IL191457A (en) | 2013-10-31 |
| AU2006314226A1 (en) | 2007-05-24 |
| WO2007057691A3 (en) | 2007-08-02 |
| CA2630441C (en) | 2013-10-29 |
| CN101346144B (zh) | 2011-07-20 |
| US20090227551A1 (en) | 2009-09-10 |
| CA2630441A1 (en) | 2007-05-24 |
| GB0523550D0 (en) | 2005-12-28 |
| JP2009515939A (ja) | 2009-04-16 |
| TWI386211B (zh) | 2013-02-21 |
| IL191457A0 (en) | 2009-08-03 |
| KR101314694B1 (ko) | 2013-10-07 |
| NO20082741L (no) | 2008-07-23 |
| KR20080073755A (ko) | 2008-08-11 |
| RU2427375C2 (ru) | 2011-08-27 |
| EP1948192A2 (en) | 2008-07-30 |
| AU2006314226B2 (en) | 2012-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0518390D0 (en) | Therapeutic compounds | |
| GB0610680D0 (en) | Therapeutic compounds | |
| IL193678A0 (en) | Therapeutic compounds | |
| GB0518237D0 (en) | Therapeutic compounds | |
| ZA200900004B (en) | Therapeutic compounds | |
| GB0603041D0 (en) | Therapeutic compounds | |
| GB0509326D0 (en) | Therapeutic compounds | |
| GB0509573D0 (en) | Therapeutic compounds | |
| GB0518361D0 (en) | Therapeutic compounds | |
| GB0522881D0 (en) | Therapeutic compounds | |
| GB0606663D0 (en) | Therapeutic compounds | |
| GB0509405D0 (en) | Therapeutic compounds | |
| GB0513747D0 (en) | Therapeutic compounds | |
| GB0615809D0 (en) | Therapeutic compounds | |
| GB0612971D0 (en) | Therapeutic compounds | |
| ZA200804266B (en) | Therapeutic uses of steroidal compounds | |
| GB0522130D0 (en) | Therapeutic compounds | |
| GB0526107D0 (en) | Therapeutic Compounds | |
| GB0518235D0 (en) | Therapeutic compounds | |
| GB0625349D0 (en) | Therapeutic compounds | |
| GB0625345D0 (en) | Therapeutic compounds | |
| GB0603455D0 (en) | Therapeutic compounds | |
| GB0605573D0 (en) | Therapeutic Compounds | |
| HK1120219A (en) | Therapeutic uses of steroidal compounds | |
| GB0608269D0 (en) | Therapeutic compounds |